Jul 2018 What’s harder, making new drugs or improving care delivery at scale? An opinionated take on NEJM highlights for July 2018 By Marc Herant NEJM RNA drugs coming of age Hereditary Transthyretin Amyloidosis (ATTR) is… Read more
